Led 2-agonists for acute bronchitis in patients without underlying pulmonary illness
Led 2-agonists for acute bronchitis in sufferers devoid of underlying pulmonary illness identified no significant advantages.9 Moreover, use of any additional medication increases the risk of harmful interactions with other…